Toll Free: 1-888-928-9744

United States Biosimilars-on-Biologics Industry 2016 Market Research Report

Published: Jun 16, 2016 | Pages: 136 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The United States Biosimilars-on-Biologics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Biosimilars-on-Biologics industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biosimilars-on-Biologics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biosimilars-on-Biologics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 148 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


 Table of Contents
1 Industry Overview 1.1 Definition and Specifications of Biosimilars-on-Biologics 1.1.1 Definition of Biosimilars-on-Biologics 1.1.2 Specifications of Biosimilars-on-Biologics 1.2 Classification of Biosimilars-on-Biologics 1.2.1 Human growth hormone 1.2.2 Erythropoietin 1.2.3 Monoclonal antibodies 1.2.4 Insulin 1.2.5 Interferon 1.2.6 Granulocyte-Colony Stimulating Factor 1.2.7 Peptide 1.3 Applications of Biosimilars-on-Biologics 1.3.1 Blood disorders 1.3.2 Oncology diseases 1.3.3 Chronic and autoimmune diseases 1.3.4 Growth hormone deficiencies 1.4 Industry Chain Structure of Biosimilars-on-Biologics 1.5 Industry Overview of Biosimilars-on-Biologics 1.6 Industry Policy Analysis of Biosimilars-on-Biologics 1.7 Industry News Analysis of Biosimilars-on-Biologics 2 Manufacturing Cost Structure Analysis of Biosimilars-on-Biologics 2.1 Bill of Materials (BOM) of Biosimilars-on-Biologics 2.2 BOM Price Analysis of Biosimilars-on-Biologics 2.3 Labor Cost Analysis of Biosimilars-on-Biologics 2.4 Depreciation Cost Analysis of Biosimilars-on-Biologics 2.5 Manufacturing Cost Structure Analysis of Biosimilars-on-Biologics 2.6 Manufacturing Process Analysis of Biosimilars-on-Biologics 2.7 United States Price, Cost and Gross of Biosimilars-on-Biologics 2011-2016 3 Technical Data and Manufacturing Plants Analysis 3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015 3.2 Manufacturing Plants Distribution of United States Key Biosimilars-on-Biologics Manufacturers in 2015 3.3 R&D Status and Technology Source of United States Biosimilars-on-Biologics Key Manufacturers in 2015 3.4 Raw Materials Sources Analysis of United States Biosimilars-on-Biologics Key Manufacturers in 2015 4 Production Analysis of Biosimilars-on-Biologics by Regions, Type, and Applications 4.1 United States Production of Biosimilars-on-Biologics by Regions 2011-2016 4.2 United States Production of Biosimilars-on-Biologics by Type 2011-2016 4.3 United States Sales of Biosimilars-on-Biologics by Applications 2011-2016 4.4 Price Analysis of United States Biosimilars-on-Biologics Key Manufacturers in 2015 4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Biosimilars-on-Biologics 2011-2016 5 Consumption Volume and Consumption Value Analysis of Biosimilars-on-Biologics by Regions 5.1 United States Consumption Volume of Biosimilars-on-Biologics by Regions 2011-2016 5.2 United States Consumption Value of Biosimilars-on-Biologics by Regions 2011-2016 5.3 United States Consumption Price Analysis of Biosimilars-on-Biologics by Regions 2011-2016 6 Analysis of Biosimilars-on-Biologics Production, Supply, Sales and Market Status 2011-2016 6.1 Capacity, Production, Sales, and Revenue of Biosimilars-on-Biologics 2011-2016 6.2 Production Market Share and Sales Market Share Analysis of Biosimilars-on-Biologics 2014-2015 6.3 Sales Overview of Biosimilars-on-Biologics 2011-2016 6.4 Supply, Consumption and Gap of Biosimilars-on-Biologics 2011-2016 6.5 Import, Export and Consumption of Biosimilars-on-Biologics 2011-2016 6.6 Cost, Price, Revenue and Gross Margin of Biosimilars-on-Biologics 2011-2016 7 Analysis of Biosimilars-on-Biologics Industry Key Manufacturers 7.1 Novartis 7.1.1 Company Profile 7.1.2 Product Picture and Specifications 7.1.2.1 Type I 7.1.2.2 Type II 7.1.2.3 Type III 7.1.3 Capacity, Production, Price, Cost, Gross and Revenue 7.1.4 Contact Information 7.2 Synthon Pharmaceuticals, Inc. 7.2.1 Company Profile 7.2.2 Product Picture and Specifications 7.2.2.1 Type I 7.2.2.2 Type II 7.2.2.3 Type III 7.2.3 Capacity, Production, Price, Cost, Gross and Revenue 7.2.4 Contact Information 7.3 Teva Pharmaceutical Industries Ltd. 7.3.1 Company Profile 7.3.2 Product Picture and Specifications 7.3.2.1 Type I 7.3.2.2 Type II 7.3.2.3 Type III 7.3.3 Capacity, Production, Price, Cost, Gross and Revenue 7.3.4 Contact Information 7.4 LG Life Sciences 7.4.1 Company Profile 7.4.2 Product Picture and Specifications 7.4.2.1 Type I 7.4.2.2 Type II 7.4.2.3 Type III 7.4.3 Capacity, Production, Price, Cost, Gross and Revenue 7.4.4 Contact Information 7.5 Celltrion 7.5.1 Company Profile 7.5.2 Product Picture and Specifications 7.5.2.1 Type I 7.5.2.2 Type II 7.5.2.3 Type III 7.5.3 Capacity, Production, Price, Cost, Gross and Revenue 7.5.4 Contact Information 7.6 Biocon 7.6.1 Company Profile 7.6.2 Product Picture and Specifications 7.6.2.1 Type I 7.6.2.2 Type II 7.6.2.3 Type III 7.6.3 Capacity, Production, Price, Cost, Gross and Revenue 7.6.4 Contact Information 7.7 Hospira 7.7.1 Company Profile 7.7.2 Product Picture and Specifications 7.7.2.1 Type I 7.7.2.2 Type II 7.7.2.3 Type III 7.7.3 Capacity, Production, Price, Cost, Gross and Revenue 7.7.4 Contact Information 7.8 Merck Serono 7.8.1 Company Profile 7.8.2 Product Picture and Specifications 7.8.2.1 Type I 7.8.2.2 Type II 7.8.2.3 Type III 7.8.3 Capacity, Production, Price, Cost, Gross and Revenue 7.8.4 Contact Information 7.9 Biogen idec Inc. 7.9.1 Company Profile 7.9.2 Product Picture and Specifications 7.9.2.1 Type I 7.9.2.2 Type II 7.9.2.3 Type III 7.9.3 Capacity, Production, Price, Cost, Gross and Revenue 7.9.4 Contact Information 8 Price and Gross Margin Analysis 8.1 Analysis of Price 8.2 Gross Margin Analysis 8.3 Price Comparison by Regions 8.4 Price Analysis of Different Biosimilars-on-Biologics Product Types 8.5 Market Share Analysis of Different Biosimilars-on-Biologics Price Levels 8.6 Gross Margin Analysis of Different Biosimilars-on-Biologics Applications 9 Marketing Trader or Distributor Analysis of Biosimilars-on-Biologics 9.1 Marketing Channels Status of Biosimilars-on-Biologics 9.2 Traders or Distributors of Biosimilars-on-Biologics with Contact Information 9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilars-on-Biologics 9.4 United States Import, Export and Trade Analysis of Biosimilars-on-Biologics 10 Development Trend of Biosimilars-on-Biologics Industry 2016-2021 10.1 Capacity and Production Overview of Biosimilars-on-Biologics 2016-2021 10.2 Production Market Share by Product Types of Biosimilars-on-Biologics 2016-2021 10.3 Sales and Sales Revenue Overview of Biosimilars-on-Biologics 2016-2021 10.4 United States Sales of Biosimilars-on-Biologics by Applications 2016-2021 10.5 Import, Export and Consumption of Biosimilars-on-Biologics 2016-2021 10.6 Cost, Price, Revenue and Gross Margin of Biosimilars-on-Biologics 2016-2021 11 Industry Chain Suppliers of Biosimilars-on-Biologics with Contact Information 11.1 Major Raw Materials Suppliers of Biosimilars-on-Biologics with Contact Information 11.2 Manufacturing Equipment Suppliers of Biosimilars-on-Biologics with Contact Information 11.3 Major Players of Biosimilars-on-Biologics with Contact Information 11.4 Key Consumers of Biosimilars-on-Biologics with Contact Information 11.5 Supply Chain Relationship Analysis of Biosimilars-on-Biologics 12 New Project Investment Feasibility Analysis of Biosimilars-on-Biologics 12.1 New Project SWOT Analysis of Biosimilars-on-Biologics 12.2 New Project Investment Feasibility Analysis of Biosimilars-on-Biologics 13 Conclusion of the United States Biosimilars-on-Biologics Industry 2016 Market Research Report
List of Tables and Figures
Figure Picture of Biosimilars-on-Biologics Table Product Specifications of Biosimilars-on-Biologics Table Classification of Biosimilars-on-Biologics Figure United States Sales Market Share of Biosimilars-on-Biologics by Product Types in 2015 Table Applications of Biosimilars-on-Biologics Figure United States Sales Market Share of Biosimilars-on-Biologics by Applications in 2015 Figure Industry Chain Structure of Biosimilars-on-Biologics Table United States Industry Overview of Biosimilars-on-Biologics Table Industry Policy of Biosimilars-on-Biologics Table Industry News List of Biosimilars-on-Biologics Table Bill of Materials (BOM) of Biosimilars-on-Biologics Table Bill of Materials (BOM) Price of Biosimilars-on-Biologics Table Labor Cost of Biosimilars-on-Biologics Table Depreciation Cost of Biosimilars-on-Biologics Table Manufacturing Cost Structure Analysis of Biosimilars-on-Biologics in 2015 Figure Manufacturing Process Analysis of Biosimilars-on-Biologics Table United States Price Analysis of Biosimilars-on-Biologics 2011-2016 (USD/Unit) Table United States Cost Analysis of Biosimilars-on-Biologics 2011-2016 (USD/Unit) Table United States Gross Analysis of Biosimilars-on-Biologics 2011-2016 Table Capacity (Unit) and Commercial Production Date of United States Biosimilars-on-Biologics Key Manufacturers in 2015 Table Manufacturing Plants Distribution of United States Key Biosimilars-on-Biologics Manufacturers in 2015 Table R&D Status and Technology Source of United States Biosimilars-on-Biologics Key Manufacturers in 2015 Table Raw Materials Sources Analysis of United States and United States Biosimilars-on-Biologics Key Manufacturers in 2015 Table United States Production of Biosimilars-on-Biologics by Regions 2011-2016 (Unit) Table United States Production Market Share of Biosimilars-on-Biologics by Regions 2011-2016 Figure United States Production Market Share of Biosimilars-on-Biologics by Regions in 2014 Figure United States Production Market Share of Biosimilars-on-Biologics by Regions in 2015 Table United States Production of Biosimilars-on-Biologics by Types in 2011-2016 (Unit) Table United States Production Market Share of Biosimilars-on-Biologics by Type in 2011-2016 Figure United States Production Market Share of Biosimilars-on-Biologics by Type in 2014 Figure United States Production Market Share of Biosimilars-on-Biologics by Type in 2015 Table United States Sales of Biosimilars-on-Biologics by Applications 2011-2016 (Unit) Table United States Production Market Share of Biosimilars-on-Biologics by Applications 2011-2016 Figure United States Production Market Share of Biosimilars-on-Biologics by Applications in 2014 Figure United States Production Market Share of Biosimilars-on-Biologics by Applications in 2015 Table Price Comparison of United States Biosimilars-on-Biologics Key Manufacturers in 2015 (USD/Unit) Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Biosimilars-on-Biologics 2011-2016 Table United States Consumption Volume of Biosimilars-on-Biologics by Regions 2011-2016 (Unit) Table United States Consumption Volume Market Share of Biosimilars-on-Biologics by Regions 2011-2016 Figure United States Consumption Volume Market Share of Biosimilars-on-Biologics by Regions in 2014 Figure United States Consumption Volume Market Share of Biosimilars-on-Biologics by Regions in 2015 Table United States Consumption Value of Biosimilars-on-Biologics by Regions 2011-2016 (M USD) Table United States Consumption Value Market Share of Biosimilars-on-Biologics by Regions 2011-2016 Figure United States Consumption Value Market Share of Biosimilars-on-Biologics by Regions in 2014 Figure United States Consumption Value Market Share of Biosimilars-on-Biologics by Regions in 2015 Table Consumption Price of Biosimilars-on-Biologics by Regions 2011-2016 (USD/Unit) Table United States and Major Manufacturers Capacity of Biosimilars-on-Biologics 2011-2016 (Unit) Table United States Capacity Market Share of Major Biosimilars-on-Biologics Manufacturers 2011-2016 Table United States and Major Manufacturers Production of Biosimilars-on-Biologics 2011-2016 (Unit) Table United States Production Market Share of Major Biosimilars-on-Biologics Manufacturers 2011-2016 Table United States and Major Manufacturers Sales of Biosimilars-on-Biologics 2011-2016 (Unit) Table United States Sales Market Share of Major Biosimilars-on-Biologics Manufacturers 2011-2016 Table United States and Major Manufacturers Sales Revenue of Biosimilars-on-Biologics 2011-2016 (M USD) Table United States Sales Revenue Market Share of Major Biosimilars-on-Biologics Manufacturers 2011-2016 Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Biosimilars-on-Biologics 2011-2016 Figure United States Capacity Utilization Rate of Biosimilars-on-Biologics 2011-2016 Figure United States Sales Revenue (M USD) and Growth Rate of Biosimilars-on-Biologics 2011-2016 Figure United States Production Market Share of Major Biosimilars-on-Biologics Manufacturers in 2014 Figure United States Production Market Share of Major Biosimilars-on-Biologics Manufacturers in 2015 Figure United States Sales Market Share of Major Biosimilars-on-Biologics Manufacturers in 2014 Figure United States Sales Market Share of Major Biosimilars-on-Biologics Manufacturers in 2015 Figure United States Sales (Unit) and Growth Rate of Biosimilars-on-Biologics 2011-2016 Table United States Supply, Consumption and Gap of Biosimilars-on-Biologics 2011-2016 (Unit) Table United States Import, Export and Consumption of Biosimilars-on-Biologics 2011-2016 (Unit) Table Price of United States Biosimilars-on-Biologics Major Manufacturers 2011-2016 (USD/Unit) Table Gross Margin of United States Biosimilars-on-Biologics Major Manufacturers 2011-2016 Table United States and Major Manufacturers Revenue of Biosimilars-on-Biologics 2011-2016 (M USD) Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biosimilars-on-Biologics 2011-2016 Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Biosimilars-on-Biologics Picture and Specifications of Novartis Table Biosimilars-on-Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2011-2016 Figure Biosimilars-on-Biologics Capacity (Unit), Production (Unit) and Growth Rate of Novartis 2011-2016 Figure Biosimilars-on-Biologics Production (Unit) and United States Market Share of Novartis 2011-2016 Table Novartis Biosimilars-on-Biologics SWOT Analysis Table Synthon Pharmaceuticals, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Biosimilars-on-Biologics Picture and Specifications of Synthon Pharmaceuticals, Inc. Table Biosimilars-on-Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Synthon Pharmaceuticals, Inc. 2011-2016 Figure Biosimilars-on-Biologics Capacity (Unit), Production (Unit) and Growth Rate of Synthon Pharmaceuticals, Inc. 2011-2016 Figure Biosimilars-on-Biologics Production (Unit) and United States Market Share of Synthon Pharmaceuticals, Inc. 2011-2016 Table Synthon Pharmaceuticals, Inc. Biosimilars-on-Biologics SWOT Analysis Table Teva Pharmaceutical Industries Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Biosimilars-on-Biologics Picture and Specifications of Teva Pharmaceutical Industries Ltd. Table Biosimilars-on-Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries Ltd. 2011-2016 Figure Biosimilars-on-Biologics Capacity (Unit), Production (Unit) and Growth Rate of Teva Pharmaceutical Industries Ltd. 2011-2016 Figure Biosimilars-on-Biologics Production (Unit) and United States Market Share of Teva Pharmaceutical Industries Ltd. 2011-2016 Table Teva Pharmaceutical Industries Ltd. Biosimilars-on-Biologics SWOT Analysis Table LG Life Sciences Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Biosimilars-on-Biologics Picture and Specifications of LG Life Sciences Table Biosimilars-on-Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of LG Life Sciences 2011-2016 Figure Biosimilars-on-Biologics Capacity (Unit), Production (Unit) and Growth Rate of LG Life Sciences 2011-2016 Figure Biosimilars-on-Biologics Production (Unit) and United States Market Share of LG Life Sciences 2011-2016 Table LG Life Sciences Biosimilars-on-Biologics SWOT Analysis Table Celltrion Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Biosimilars-on-Biologics Picture and Specifications of Celltrion Table Biosimilars-on-Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Celltrion 2011-2016 Figure Biosimilars-on-Biologics Capacity (Unit), Production (Unit) and Growth Rate of Celltrion 2011-2016 Figure Biosimilars-on-Biologics Production (Unit) and United States Market Share of Celltrion 2011-2016 Table Celltrion Biosimilars-on-Biologics SWOT Analysis Table Biocon Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Biosimilars-on-Biologics Picture and Specifications of Biocon Table Biosimilars-on-Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biocon 2011-2016 Figure Biosimilars-on-Biologics Capacity (Unit), Production (Unit) and Growth Rate of Biocon 2011-2016 Figure Biosimilars-on-Biologics Production (Unit) and United States Market Share of Biocon 2011-2016 Table Biocon Biosimilars-on-Biologics SWOT Analysis Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Biosimilars-on-Biologics Picture and Specifications of Hospira Table Biosimilars-on-Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Hospira 2011-2016 Figure Biosimilars-on-Biologics Capacity (Unit), Production (Unit) and Growth Rate of Hospira 2011-2016 Figure Biosimilars-on-Biologics Production (Unit) and United States Market Share of Hospira 2011-2016 Table Hospira Biosimilars-on-Biologics SWOT Analysis Table Merck Serono Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Biosimilars-on-Biologics Picture and Specifications of Merck Serono Table Biosimilars-on-Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Merck Serono 2011-2016 Figure Biosimilars-on-Biologics Capacity (Unit), Production (Unit) and Growth Rate of Merck Serono 2011-2016 Figure Biosimilars-on-Biologics Production (Unit) and United States Market Share of Merck Serono 2011-2016 Table Merck Serono Biosimilars-on-Biologics SWOT Analysis Table Biogen idec Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Biosimilars-on-Biologics Picture and Specifications of Biogen idec Inc. Table Biosimilars-on-Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biogen idec Inc. 2011-2016 Figure Biosimilars-on-Biologics Capacity (Unit), Production (Unit) and Growth Rate of Biogen idec Inc. 2011-2016 Figure Biosimilars-on-Biologics Production (Unit) and United States Market Share of Biogen idec Inc. 2011-2016 Table Biogen idec Inc. Biosimilars-on-Biologics SWOT Analysis Table Biosimilars-on-Biologics Price by Regions 2011-2016 Table Biosimilars-on-Biologics Price by Product Types 2011-2016 Table Biosimilars-on-Biologics Price by Companies 2011-2016 Table Biosimilars-on-Biologics Gross Margin by Companies 2011-2016 Table Price Comparison of Biosimilars-on-Biologics by Regions 2011-2016 (USD/Unit) Table Price of Different Biosimilars-on-Biologics Product Types (USD/Unit) Table Market Share of Different Biosimilars-on-Biologics Price Level Table Gross Margin of Different Biosimilars-on-Biologics Applications Table Marketing Channels Status of Biosimilars-on-Biologics Table Traders or Distributors of Biosimilars-on-Biologics with Contact Information Table Ex-work Price, Channel Price and End Buyer Price of Biosimilars-on-Biologics (USD/Unit) in 2015 Table United States Import, Export, and Trade of Biosimilars-on-Biologics (Unit) Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Biosimilars-on-Biologics 2016-2021 Figure United States Capacity Utilization Rate of Biosimilars-on-Biologics 2016-2021 Table United States Biosimilars-on-Biologics Production by Type 2016-2021 (Unit) Table United States Biosimilars-on-Biologics Production Market Share by Type 2016-2021 Figure United States Production Market Share of Biosimilars-on-Biologics by Type in 2021 Figure United States Sales (Unit) and Growth Rate of Biosimilars-on-Biologics 2016-2021 Figure United States Sales Revenue (Million USD) and Growth Rate of Biosimilars-on-Biologics 2016-2021 Figure United States Sales of Biosimilars-on-Biologics by Applications 2016-2021 (Unit) Table United States Production Market Share of Biosimilars-on-Biologics by Applications 2016-2021 Figure United States Production Market Share of Biosimilars-on-Biologics by Applications in 2021 Table United States Production, Import, Export and Consumption of Biosimilars-on-Biologics 2016-2021 (Unit) Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biosimilars-on-Biologics 2016-2021 Table Major Raw Materials Suppliers of Biosimilars-on-Biologics with Contact Information Table Manufacturing Equipment Suppliers of Biosimilars-on-Biologics with Contact Information Table Major Players of Biosimilars-on-Biologics with Contact Information Table Key Consumers of Biosimilars-on-Biologics with Contact Information Table Supply Chain Relationship Analysis of Biosimilars-on-Biologics Table New Project SWOT Analysis of Biosimilars-on-Biologics Table New Project Investment Feasibility Analysis of Biosimilars-on-Biologics Table Part of Interviewees Record List



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the i

Read More...

Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving cream

Read More...

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...

Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing i

Read More...

Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast period

Read More...
Choose License Type
Single User - US $3800
Multi User - US $7600
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify